Altamira Therapeutics Ltd.
NasdaqCM:CYTO
$ 1.65
+ $0.01 (0.61%)
$ 1.65
+ $0.01 (0.61%)
End-of-day quote: 05/06/2024

Altamira Therapeutics financials at a glance

This company has not reported earnings yet.

Financials

Year Year TTM
Rev. Revenue N/A
GM % Gross Margin % -,285.58%
OM Operating Margin 0.00%
EPS Earnings Per Share $-9.04
Div. Dividends N/A
PR % Payout Ratio % 0
Sha. Shares N/AM
OCF Operating Cash Flow N/A
FCF Free Cash Flow N/A
FCFS Free Cash Flow Per Share $-4.36